3/19
04:05 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
Low
Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
3/18
11:38 am
glue
Form S-8 Monte Rosa Therapeutics,
Low
Report
Form S-8 Monte Rosa Therapeutics,
3/17
07:15 am
glue
Form 10-K Monte Rosa Therapeutics, For: Dec 31
Low
Report
Form 10-K Monte Rosa Therapeutics, For: Dec 31
3/17
07:04 am
glue
Form 8-K Monte Rosa Therapeutics, For: Mar 17
Low
Report
Form 8-K Monte Rosa Therapeutics, For: Mar 17
3/5
05:24 pm
glue
Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
Low
Report
Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
3/4
04:50 pm
glue
Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
Medium
Report
Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
3/4
04:45 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
3/2
05:03 pm
glue
Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
Low
Report
Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
3/2
04:25 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Low
Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
3/2
04:16 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Low
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
2/27
04:29 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
2/24
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Feb 23 Filed by: Janku Filip
Medium
Report
Form 4 Monte Rosa Therapeutics, For: Feb 23 Filed by: Janku Filip
2/23
05:42 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
2/17
04:15 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
2/17
04:12 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
2/11
04:37 pm
glue
Form S-3ASR Monte Rosa Therapeutics,
Low
Report
Form S-3ASR Monte Rosa Therapeutics,
2/10
04:02 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Feb 09
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Feb 09
1/21
11:59 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
1/9
04:32 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 08
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 08
1/9
04:31 pm
glue
Form 424B5 Monte Rosa Therapeutics,
Medium
Report
Form 424B5 Monte Rosa Therapeutics,
1/9
04:19 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Medium
Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
1/9
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Jan 07 Filed by: Warmuth Markus
Low
Report
Form 4 Monte Rosa Therapeutics, For: Jan 07 Filed by: Warmuth Markus
1/8
02:19 pm
glue
Form 144/A Monte Rosa Therapeutics, Filed by: Warmuth Markus
Low
Report
Form 144/A Monte Rosa Therapeutics, Filed by: Warmuth Markus
1/7
04:58 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
1/7
04:18 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Jan 07
High
Report
Form 8-K Monte Rosa Therapeutics, For: Jan 07